Company
MediWound Ltd. (MDWD)
Standardized SEC financial data for MediWound Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001593984 · NASDAQ · Medicinal Chemicals & Botanical Products.
Gross margin
56.4%
Net margin
-413.9%
Revenue growth (YoY)
-15.6%
Return on equity
-54.7%
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $21.8M | $23.8M | $26.5M | $18.7M | $20.2M | $17.0M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total assets | $31.1M | $19.7M | $50.0M | $66.5M | $73.5M | $86.3M |
| Total liabilities |
Get MDWD data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MDWD/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MDWD/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"